Improving experimental hepatic fibrosis; reducing liver fibrosis markers (HA, LN, PIIINP, Hyp, col III/IV, α-SMA); regulating TGF-β1/Smads and Wnt/ β-catenin signaling pathways. The gene discussed is ACTA1; the disease is Hepatic fibrosis.